abemaciclib
Showing 26 - 50 of 137
Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in Duarte
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Abemaciclib
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 1, 2022
Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)
Recruiting
- Myelofibrosis Due to and Following Polycythemia Vera
- Ruxolitinib
- Abemaciclib
-
Basking Ridge, New Jersey
- +6 more
Jan 26, 2023
Adenocarcinoma of Endometrium Trial in United States (Fulvestrant, Abemaciclib)
Recruiting
- Adenocarcinoma of Endometrium
- Fulvestrant
- Abemaciclib
-
Basking Ridge, New Jersey
- +6 more
Oct 12, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San
Recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Abemaciclib
- Lutetium Lu 177-PSMA-617
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 8, 2022
Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)
Not yet recruiting
- Prostatic Neoplasms
- Abemaciclib
- +2 more
-
Mineola, New York
- +14 more
Aug 23, 2023
Advanced Dedifferentiated Liposarcoma Trial in United States (Abemaciclib, Placebo)
Recruiting
- Advanced Dedifferentiated Liposarcoma
- Abemaciclib
- Placebo
-
Jacksonville, Florida
- +6 more
Jul 27, 2022
Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET
Suspended
- Metastatic Malignant Solid Neoplasm
- +3 more
- Abemaciclib
- +3 more
-
Boston, MassachusettsDana-Farber - Harvard Cancer Center LAO
Sep 17, 2022
HNSCC Trial in Tucson (Abemaciclib)
Recruiting
- HNSCC
- Abemaciclib
-
Tucson, ArizonaUniversity of Arizona
Mar 3, 2022
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,
Recruiting
- Metastatic Breast Cancer
- +2 more
- Abemaciclib
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jun 7, 2022
Breast Cancer Trial in Philadelphia (Abemaciclib, Hydroxychloroquine)
Recruiting
- Breast Cancer
- Abemaciclib
- Hydroxychloroquine
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Dec 13, 2021
Abemaciclib in Combination With Endocrine Therapy as First Line
Recruiting
- Breast Cancer/ Metastatic Breast Cancer
- Abemaciclib
-
Munich, GermanyKlinikum rechts der Isar der TU München, Klinik und Poliklinik f
Apr 26, 2022
Cancer Metastatic Trial in Pierre Benite, Rennes (Paclitaxel injection, Capecitabine tablets, Letrozole 2.5mg)
Recruiting
- Cancer Metastatic
- Paclitaxel injection
- +5 more
-
Pierre Benite, France
- +1 more
May 11, 2022
Esophageal Adenocarcinoma, Esophagus SCC, Cholangiocarcinoma Trial in Belgium, France (Abemaciclib)
Active, not recruiting
- Esophageal Adenocarcinoma
- +4 more
- Abemaciclib
-
Antwerpen, Belgium
- +10 more
May 27, 2022
Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)
Not yet recruiting
- Advanced Breast Cancer
- Fulvestrant
- +4 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Jun 28, 2023
Biliary Tract Carcinoma Trial in Hershey (Abemaciclib)
Recruiting
- Biliary Tract Carcinoma
- Abemaciclib
-
Hershey, PennsylvaniaPenn State Cancer Institute
Feb 3, 2022
Bladder Cancer Trial in United States (Abemaciclib)
Recruiting
- Bladder Cancer
- Abemaciclib
-
Tampa, Florida
- +3 more
Jul 27, 2022
Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)
Recruiting
- Chondrosarcoma
- +2 more
- Abemaciclib
-
Jacksonville, Florida
- +3 more
Apr 4, 2022
Brain Tumor Trial in United States (abemaciclib)
Active, not recruiting
- Brain Tumor
- abemaciclib
-
Hartford, Connecticut
- +7 more
Mar 30, 2022
Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in United States
Suspended
- Recurrent Ovarian High Grade Serous Adenocarcinoma
- Recurrent Platinum-Resistant Ovarian Carcinoma
- Abemaciclib
- Olaparib
-
Phoenix, Arizona
- +8 more
Jul 26, 2022
Head Neck Cancer, Advanced Cancer, Metastatic Cancer Trial in Bordeaux, Lyon, Nice (Abemaciclib)
Recruiting
- Head and Neck Cancer
- +2 more
- Abemaciclib
-
Bordeaux, France
- +2 more
Jul 22, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +4 more
- Abemaciclib
- +2 more
-
Birmingham, Alabama
- +12 more
Nov 9, 2022